ArticleCancers2023

A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors.

Gary Edward Richardson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.